AMT Medical raises €25 million for bypass procedure without open-Heart surgery
AMT Medical, a medtech company based in Ede and Utrecht, has announced the closing of a €25 million funding round. The round was led by Bender Analytical Holding, with participation from Invest-NL, the European Innovation Council (EIC), and existing investors. This milestone accelerates AMT’s mission to make open-heart bypass surgery obsolete through its groundbreaking ELANA® Heart Bypass System.
A revolution in cardiac surgery: key innovations
The ELANA® Heart Bypass System enables surgeons to perform a highly advanced form of coronary artery bypass grafting (CABG) using arterial rather than venous grafts. This is done through small incisions in the chest, while the heart continues to beat, and without the use of a heart-lung machine. As a result, the risk of stroke and other complications is significantly reduced, and patients recover much faster. This represents a major shift from traditional methods, which require opening the chest, stopping the heart, and involve lengthy recovery times.
The technique uses a specialized clip and an excimer laser to connect blood vessels, eliminating the need for manual suturing. This enables fast, precise, and reliable vessel connections with fewer complications.
Moreover, the system cuts costs by over 50% when used in combination with surgical robots— thanks to shorter operating room times, reduced hospital stays, fewer complications, and a faster learning curve for surgeons compared to traditional bypass surgery.
Next steps
With CE marking expected by 2026 and clinical trials in the U.S. on the horizon, this funding will support:
- Completion of our European first-in-human trial (results late 2025)
- Expansion into robotic-assisted keyhole surgery, partnering with industry leaders
- A future where 1 million patients annually benefit from safer, faster cardiac care
Rutger Tulleken, CEO of AMT Medical, said: “This financing validates our vision to obsolete open-heart bypass. By enabling same-day discharge procedures, we’re not just improving outcomes—we’re rewriting the future of cardiovascular care.”
Educate for tomorrow’s healthcare with 3D printing
With a new minor in medical 3D bioprinting, HU University of Applied Sciences Utrecht and the University Medical Center Utrecht are training students for the healthcare of the future, in which 3D printing technology is playing an increasingly important role.
GenDx is ‘Fit to Donate’ and goes the extra mile to raise funds for Stichting Matchis
With the ‘GenDx Tulip Run’, colleagues, friends and family raised €3,850 for Matchis, good for one new potential stem cell donor per employee.
UU researchers contribute to Global Tipping Points Report
UU scientists from the Institute for Marine and Atmospheric Research Utrecht investigated the Atlantic Ocean circulation and show that a sudden weakening can have major consequences for the global climate.
Utrecht Science Week anniversary edition a great success
The fifth edition of Utrecht Science Week was a resounding success! With more programs, locations, speakers, and visitors than ever before, we look back on an exciting week. The variety of programs and the diverse audience were wonderful to witness. This way, the groundbreaking research here at Utrecht Science Park isn’t kept behind closed doors, but is given the opportunity to inspire others.